News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
HURWITZ EDWARD
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/02/2023 |
4
| HURWITZ EDWARD (Director) has filed a Form 4 on MACROGENICS INC|
Txns:
| Granted 19,000 options to buy
@ $4.67, valued at
$88.7k
Granted 4,500 restricted stock units
@ $0 |
|
| 05/25/2023 |
4
| HURWITZ EDWARD (Director) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Granted 24,900 options to buy
@ $13.49, valued at
$335.9k
|
|
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| HURWITZ EDWARD (Director) has filed a Form 4 on MACROGENICS INC|
Txns:
| Granted 18,000 options to buy
@ $3.9, valued at
$70.2k
|
|
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| HURWITZ EDWARD (Director) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Granted 19,596 options to buy
@ $19.56, valued at
$383.3k
|
|
| 05/17/2021 |
4
| HURWITZ EDWARD (Director) has filed a Form 4 on MACROGENICS INC|
Txns:
| Granted 15,000 options to buy
@ $28.88, valued at
$433.2k
|
|
| 12/18/2020 |
4
| HURWITZ EDWARD (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP|
Txns:
| Granted 12,000 options to buy
@ $4.72, valued at
$56.6k
|
|
| 09/23/2020 |
4
| HURWITZ EDWARD (10% Owner) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Converted 4,614,943 shares
@ $0
Converted 245,279 shares
@ $0
Converted 91,081 shares
@ $0
Bought 4,893,347 preferred shares
@ $1, valued at
$4.9M
Bought 260,077 preferred shares
@ $1, valued at
$260.1k
Bought 96,576 preferred shares
@ $1, valued at
$96.6k
Bought 1,326,313 preferred shares
@ $2.811, valued at
$3.7M
Bought 70,492 preferred shares
@ $2.811, valued at
$198.2k
Bought 26,176 preferred shares
@ $2.811, valued at
$73.6k
Converted 13,980,992 preferred shares
@ $0
Converted 743,076 preferred shares
@ $0 |
|
| 05/15/2020 |
4
| HURWITZ EDWARD (Director) has filed a Form 4 on MACROGENICS INC|
Txns:
| Granted 15,000 options to buy
@ $24.97, valued at
$374.6k
|
|
| 12/06/2019 |
4
| HURWITZ EDWARD (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP|
Txns:
| Granted 10,000 options to buy
@ $3.02, valued at
$30.2k
|
|
| 05/20/2019 |
4
| HURWITZ EDWARD (Director) has filed a Form 4 on MACROGENICS INC|
Txns:
| Granted 10,000 options to buy
@ $18, valued at
$180k
|
|
| 11/19/2018 |
4
| HURWITZ EDWARD (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP|
Txns:
| Granted 10,000 options to buy
@ $6.9, valued at
$69k
|
|
| 07/27/2018 |
4
| HURWITZ EDWARD (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP|
Txns:
| Granted 8,000 options to buy
@ $4.25, valued at
$34k
|
|
| 05/29/2018 |
4
| HURWITZ EDWARD (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP|
Txns:
| Acquired 25,672 shares
@ $0 |
|
| 05/21/2018 |
4
| HURWITZ EDWARD (Director) has filed a Form 4 on MACROGENICS INC|
Txns:
| Granted 10,000 options to buy
@ $21.34, valued at
$213.4k
|
|
| 05/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/20/2016 |
4
| HURWITZ EDWARD (Director) has filed a Form 4 on MACROGENICS INC |
| 10/18/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/11/2013 |
4
| HURWITZ EDWARD (Director) has filed a Form 4 on MACROGENICS INC|
Txns:
| Granted 13,849 options to buy
@ $16, valued at
$221.6k
|
|
| 10/17/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/02/2012 |
4
| HURWITZ EDWARD (Director) has filed a Form 4 on SUNESIS PHARMACEUTICALS INC|
Txns:
| Granted 25,000 options to buy
@ $2.87, valued at
$71.8k
|
|
| 08/09/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/05/2011 |
4
| HURWITZ EDWARD (Director) has filed a Form 4 on SUNESIS PHARMACEUTICALS INC|
Txns:
| Granted 50,000 options to buy
@ $2.09, valued at
$104.5k
|
|
| 10/27/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/02/2010 |
4
| HURWITZ EDWARD (Director) has filed a Form 4 on SUNESIS PHARMACEUTICALS INC|
Txns:
| Granted 10,910,596 shares
@ $0.275, valued at
$3M
Granted 732,745 shares
@ $0.275, valued at
$201.5k
Granted 268,883 shares
@ $0.275, valued at
$73.9k
Converted 4,577,280 shares
@ $0
Converted 307,390 shares
@ $0
Converted 112,800 shares
@ $0
Converted 457,728 preferred shares
@ $0
Converted 30,739 preferred shares
@ $0
Converted 11,280 options to buy
@ $0 |
|
| 06/08/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/16/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/03/2009 |
4
| HURWITZ EDWARD (10% Owner) has filed a Form 4 on SUNESIS PHARMACEUTICALS INC |
| 10/06/2009 |
4
| ALTA BIOPHARMA PARTNERS III LP (Former 10% owner) has filed a Form 4 on THRESHOLD PHARMACEUTICALS INC |
| 09/08/2009 |
4
| Alta Partners III, Inc. (Former 10% owner) has filed a Form 4 on TorreyPines Therapeutics, Inc. |
| 06/19/2009 |
4
| HURWITZ EDWARD (Director) has filed a Form 4 on SUNESIS PHARMACEUTICALS INC |
|
|